Gewählte Publikation:
SHR
Neuro
Krebs
Kardio
Lipid
Stoffw
Microb
Dold, L; Lutz, P; Heine, A; Weismuller, TJ; Strassburg, CP; Spengler, U.
Ruxolitinib for treatment of polycythemia vera and myelofibrosis in patients after liver transplantation
CLIN CASE REP. 2021; 9(9): e04782
Doi: 10.1002/ccr3.4782
[OPEN ACCESS]
Web of Science
PubMed
FullText
FullText_MUG
- Co-Autor*innen der Med Uni Graz
-
Heine Annkristin
- Altmetrics:
- Dimensions Citations:
- Plum Analytics:
- Scite (citation analytics):
- Abstract:
- Although ruxolitinib contributes to immunomodulation and can lead to severe infections, it seems a feasible treatment strategy for patients with polycythemia vera and myelofibrosis after liver transplantation.
- Find related publications in this database (Keywords)
-
liver transplantation
-
myelofibrosis
-
polycythemia vera
-
ruxolitinib